| Geld/Brief | 14,45 $ / 19,57 $ |
| Spread | +35,43% |
| Schluss Vortag | 18,145 $ |
| Gehandelte Stücke | 179.971 |
| Tagesvolumen Vortag | 2.248.096 $ |
| Tagestief 17,72 $ Tageshoch 18,195 $ | |
| 52W-Tief - 52W-Hoch 18,04 $ | |
| Jahrestief - Jahreshoch 18,04 $ | |
| Umsatz in Mio. | 3.102 $ |
| Operatives Ergebnis (EBIT) in Mio. | - |
| Jahresüberschuss in Mio. | -331,00 $ |
| Umsatz je Aktie | 12,09 $ |
| Gewinn je Aktie | -1,23 $ |
| Gewinnrendite | -10,67% |
| Umsatzrendite | -10,67% |
| Return on Investment | -7,15% |
| Marktkapitalisierung in Mio. | 4.962 $ |
| KGV (Kurs/Gewinn) | -10,03 |
| KBV (Kurs/Buchwert) | 0,92 |
| KUV (Kurs/Umsatz) | 1,07 |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +77,99% |
| Faktor-Zertifikate | 22 | |
| Knock-Outs | 18 |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 18,09 $ | -1,31% | 18,33 $ | 31.07.26 | |
| Düsseldorf | 15,50 € | -0,64% | 15,60 € | 31.07.26 | |
| Frankfurt | 15,65 € | -0,95% | 15,80 € | 31.07.26 | |
| Gettex | 15,60 € | -2,50% | 16,00 € | 31.07.26 | |
| L&S RT | 15,65 € | -0,63% | 15,75 € | 31.07.26 | |
| München | 15,75 € | 0 % | 15,75 € | 31.07.26 | |
| Nasdaq | 18,04 $ | -0,58% | 18,145 $ | 31.07.26 | |
| NYSE | 18,14 $ | +0,08% | 18,125 $ | 31.07.26 | |
| Quotrix | 15,85 € | -3,06% | 16,35 € | 31.07.26 | |
| Stuttgart | 15,70 € | -1,88% | 16,00 € | 31.07.26 | |
| Tradegate | 15,434 € | -1,92% | 15,736 € | 31.07.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 31.07.26 | 18,04 | 2,06 M |
| 30.07.26 | 18,145 | 2,25 M |
| 29.07.26 | 18,40 | 2,94 M |
| 28.07.26 | 17,64 | 3,29 M |
| 27.07.26 | 17,67 | 3,46 M |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 16,83 $ | +7,19% |
| 1 Monat | 15,19 $ | +18,76% |
| 6 Monate | - | - |
| 1 Jahr | - | - |
| 5 Jahre | - | - |
| Marktkapitalisierung | 4,96 Mrd. $ |
| Streubesitz | 9,98% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Medizinische Instrumente & Zubehör |
| Aktientyp | Stammaktie |
| +2,45% | Massachusetts Financial Services Company |
| +1,54% | MFS Mid Cap Value Equity |
| +1,13% | Longaeva Partners L.P. |
| +1,02% | Citadel Advisors Llc |
| +0,92% | Millennium Management LLC |
| +0,71% | Alyeska Investment Group, L.P. |
| +0,71% | Sessa Capital, L.P |
| +0,54% | Hood River Capital Management LLC |
| +0,49% | FMR Inc |
| +0,46% | Fidelity Select Medical Tech and Devcs |
| +0,41% | Point72 Asset Management, L.P. |
| +0,38% | Rock Springs Capital Management LP |
| +0,30% | Balyasny Asset Management LLC |
| +0,30% | Boston Partners Global Investors, Inc |
| +0,27% | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
| +0,26% | MFS Mid Cap Growth Equity |
| +0,18% | JNL/MFS Mid Cap Value A |
| +0,17% | Bridge Builder Small/Mid Cap Value |
| +0,16% | D. E. Shaw & Co LP |
| +0,15% | ExodusPoint Capital Management, LP |
| +0,12% | Vanguard Institutional Extnd Mkt Idx Tr |
| +0,11% | Parkman Healthcare Partners LLC |
| +0,11% | Readystate Asset Management LP |
| +0,11% | UBS Group AG |
| +0,11% | OZ Management LLC |
| +0,11% | The Goldman Sachs Group Inc |
| +0,11% | Burkehill Global Management, LP |
| +0,10% | BlueCrest Capital Management Ltd. |
| +0,07% | Russell 2000 Index Non-Lendable Fund |
| +0,07% | Russell 2000 Equity Index Fund B |
| +0,06% | Vanguard Russell 2000 ETF |
| +0,06% | MFS Mid Cap Growth fund Class 2 |
| +0,06% | Fidelity Nasdaq Composite Index |
| +0,05% | Schwab US Small-Cap ETF™ |
| +0,04% | State St Russell Sm Cap® Idx SL Cl I |
| +0,04% | First Trust US Equity Opportunities ETF |
| +0,03% | Fidelity Nasdaq Composite ETF |
| +0,03% | Boston Partners Small Cap Value Equity |
| +0,03% | Boston Partners Small Cap Value SMA |
| +0,03% | MFS Mid Cap Value IS SP |
| +0,02% | Schwab Small Cap Index |
| +0,02% | NT R2000 Index Fund - NL |
| +0,02% | BlackRock Extended Equity Market Fund K |
| +0,02% | AST Small-Cap Equity Portfolio |
| +0,02% | Boston Partners Small/Mid Cap Value Eq A |
| +0,02% | Hood River New Opportunities CIT Fdrs Cl |
| +0,02% | Hood River New Opportunities |
| +0,01% | Goldman Sachs Innovate Equity ETF |
| +0,01% | NCIT MFS Mid Cap Value Fund Class B |
| +0,01% | MFS Active Mid Cap ETF |
| +0,01% | Boston Partners SC Val II CIT Shr Cl D |
| +0,01% | Boston Partners SMID Cap Value SMA |
| +0,01% | Boston Partners SMID Cap Value Equity |
| +0,01% | LVIP Blended Mid Cap Managed Vol Std |
| +9,98% | Streubesitz |
| +9,98% | Individuelle Aktionäre |